Company Filing History:
Years Active: 2009-2010
Title: Innovations by Jennifer Stover
Introduction
Jennifer Stover is an accomplished inventor based in Topsfield, MA (US). She has made significant contributions to the field of medical diagnostics and drug monitoring. With a total of 2 patents, her work focuses on innovative methods that enhance the understanding and treatment of various diseases.
Latest Patents
Jennifer's latest patents include groundbreaking inventions. The first patent is titled "Methods for monitoring drug activities in vivo." This invention outlines methods, systems, and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. It identifies numerous drug activity genes that can be modulated by CCI-779 or other drugs, allowing these genes to serve as surrogate markers for detecting or monitoring drug activities in vivo. The second patent is "Methods for diagnosing RCC and other solid tumors." This invention provides methods, systems, and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. It identifies disease genes that are differentially expressed in the peripheral blood of patients with RCC or other solid tumors compared to disease-free individuals, enabling the use of these genes as surrogate markers for diagnosis.
Career Highlights
Jennifer Stover is currently associated with Wyeth, a prominent company in the pharmaceutical industry. Her work at Wyeth has allowed her to focus on innovative solutions that address critical health challenges.
Collaborations
Some of her notable coworkers include Natalie C Twine and Michael E Burczynski. Their collaboration has contributed to the advancement of research and development in their respective fields.
Conclusion
Jennifer Stover's contributions to medical diagnostics and drug monitoring through her patents demonstrate her commitment to innovation in healthcare. Her work continues to pave the way for advancements in the detection and treatment of serious diseases.